FolioLanternBeta
MANEVeradermics, Inc

John Childs

Director at Veradermics, Inc, as of Aug 14, 2026Sold $10.7M of stock in the past 12 months: 100% with no plan disclosed. Bought $10.0M of stock in 2 open-market purchases.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
100K
shares sold, past 12 months
1
days with sales
$10.7M
largest single day, Aug 12, 2026
$10.0M
open-market purchases, past 12 months (2 trades)
1
company filed for

Share of stake sold and shares held at Veradermics, Inc are not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJunJulAug 2026: $10.7M no plan disclosed$10.7MAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Veradermics, Inc (MANE)DirectorFeb 3, 2026Aug 14, 2026

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.